Watchmaker Genomics launches Stellar RT-qPCR and qPCR Kits
Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026
Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026
Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies
Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets
Expanded CFTR variant coverage designed to align with updated professional recommendations
After years of research, gene therapy is entering clinics worldwide, bringing new expectations and new responsibilities for diagnostic laboratories
Collaboration aims to discover and develop antibodies against multiple therapeutic targets designated by Merck
The U.S. FDA has cleared the Investigational New Drug (IND) application for ABSK061, a highly selective small-molecule FGFR2/3 inhibitor, for the treatment of children with achondroplasia (ACH)
Equipped with the READY System to make structural biology research accessible to more labs
Guest editorial by Milestone explores the benefits of microwave technology in elemental analysis, organic contaminant testing, and nutritional and compositional profiling of food samples
Prospective UT MD Anderson study shows RNA analysis expands on treatment options beyond DNA testing
See how Honeywell and METTLER TOLEDO collaborated to unlock new frontiers for Hydranal reagent formulation via automated titration